Characteristics of COVID-19 and mortality-associated factors during the first year of the pandemic in southeast Mexico

Author:

Rangel-Méndez Jorge A1ORCID,Jaimes-Gurrusquieta Luciola2,Sánchez-Cruz Juan F3ORCID,Zarate-Murillo Ma I2,Domínguez-Méndez Jessica4,Laviada-Molina Hugo A5ORCID,Casares-González Daniel5,Flores-Flores Elideth M2ORCID

Affiliation:

1. Centro de Investigaciones Regionales “Dr. Hideyo Noguchi,” Universidad Autónoma de Yucatán, Mérida, Yucatán, 97225, México

2. Unidad de Medicina Familiar 58. Instituto Mexicano del Seguro Social (IMSS), Mérida, Yucatán, 97285, México

3. Coordinación de Investigación en Salud del IMSS en Yucatán, Mérida, Yucatán, 97155, México

4. Unidad de Medicina Familiar 59, Instituto Mexicano del Seguro Social, Mérida, Yucatán, 97160, México

5. Universidad Marista de Mérida, Escuela de Ciencias de la Salud, Mérida, Yucatán, 97300, México

Abstract

Aim: The present study was designed to evaluate the clinical characteristics of COVID-19 and mortality-associated factors during the first year of the pandemic in patients from southeastern Mexico. Patient & methods: A total of 953 records from patients with COVID-19 were cross-sectionally studied in a primary care hospital in southeast Mexico between 2020 and 2021. Results: The prevalent symptoms were fever (78.6%), cough (80.5%) and headache (82.8%) and dyspnea reached 13.5%. The mortality rate was 7.63% and the clinical variables associated with it were age >60 years, hypertension, severe disease, radiographic pneumonia, days to diagnosis and having two Mayan surnames. Conclusion: Future health strategies should consider age, comorbidities, disease severity, clinical manifestations and possessing ethnicity of risk (i.e., Mayan genetic background).

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

Reference42 articles.

1. WHO. WHO Director-General's opening remarks at the media briefing on COVID-19 (2020). www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020

2. WHO. Coronavirus disease (COVID-19) situation dashboard (2022). https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd

3. WHO. Tracking SARS-CoV-2 variants (2022). www.who.int/en/activities/tracking-SARS-CoV-2-variants/

4. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis

5. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3